Back to
Citadel Advisors LLC
RDHL
5 quarters
Position history for
Citadel Advisors LLC's holdings in Redhill Biopharma Ltd.
Yes. Citadel Advisors holds 65,321 shares of RDHL (Redhill Biopharma), worth $55,196, as of its Q2 2026 13F filing. It increased the position from 20,673 shares in Q1 2026. Citadel Advisors has held RDHL since Q4 2025, across 3 quarterly 13F filings.
Current Value
$55,196
Current Shares
65,321
Total Value Change
-$2,026
Total Shares Change
+43,809
Quarter-by-Quarter History
Other major holders of RDHL: Fédération des caisses Desjardins du Québec, UBS Group AG, Morgan Stanley